Literature DB >> 6877164

Extradural haematoma in children. Primary and secondary lucid intervals.

P E Oatey, T A Dinning, D A Simpson.   

Abstract

Twenty-six cases of extradural haematoma in children were reviewed over a 10-year period. The incidence of extradural haematoma was 3.3/1000 patients admitted to hospital with head injuries. Of 26 patients, 23% had no skull fracture and, in a further 8%, the fracture was not radiographically detectable. Twenty-three per cent of patients showed papilloedema, and 50% exhibited a fixed dilated ipsilateral pupil. In 62% of patients, there was no initial loss of consciousness; in a further 19%, impairment of consciousness was brief or doubtful. The lucid interval lasted three hours or less in one-third of patients; 24 hours after injury, the level of consciousness had declined in 73% of patients. Of particular interest was the occurrence of a secondary lucid interval, definite and dramatic in 8% of patients, and definite, but slight, in a further 12%. All patients made a good recovery, except one, who died from massive pulmonary fat embolism.

Entities:  

Mesh:

Year:  1983        PMID: 6877164     DOI: 10.5694/j.1326-5377.1983.tb122399.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

1.  Extradural haemorrhage in infancy and childhood. A review of 35 years' experience in South Australia.

Authors:  C J Molloy; K A McCaul; A J McLean; J B North; D A Simpson
Journal:  Childs Nerv Syst       Date:  1990-11       Impact factor: 1.475

2.  Extradural haematoma. Report of 37 consecutive cases with survival.

Authors:  S Paterniti; P Fiore; E Macrì; G Marra; M Cambria; F Falcone; S Cambria
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

3.  Clinical characteristics of traumatic extradural hematoma: a comparison between children and adults.

Authors:  A Jamjoom; B Cummins; Z A Jamjoom
Journal:  Neurosurg Rev       Date:  1994       Impact factor: 3.042

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.